mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
MS-275 |
FIMM |
pan-cancer |
AAC |
0.29 |
0.03 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.04 |